(phenyl acetic, phenylpropionic, urolithin, etc) that may exert
systemic effects. Also, non-absorbable metabolites and non-fermented
antioxidants remaining in the colonic lumenmay counteract
dietary pro-oxidants. A more oxidant status in the colon has been
observed in colorectal cancer patients (Chang et al., 2008